Inhibition of lung cancer proliferation by antisense cyclin D

Cancer Gene Therapy

Volumn 3, Issue 2, 1996, Pages 131-135

  Schrump, David S ^a  

^a Dept of Thorac/Cardiovasc Surgery   (United States)

Author keywords

Antisense; Cyclin D; Gene therapy; Lung cancer

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLIN D; CYCLINE; RETINOBLASTOMA PROTEIN; URETHAN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CELL CULTURE; CELL CYCLE; CELL DIVISION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; LUNG TUMOR; METHODOLOGY; MOUSE; NORTHERN BLOTTING; NUDE MOUSE; PATHOLOGY;

ANIMALS; BLOTTING, NORTHERN; CELL CYCLE; CELL DIVISION; CYCLINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDES, ANTISENSE; RETINOBLASTOMA PROTEIN; SUPPRESSION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; URETHANE;

EID: 0030101829     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Rodenhuis S, Slebos RJC. Clinical significance of ras oncogene activation in human lung cancer. Cancer Res. 1992;52(suppl):2665-2669.
2. Reissman PT, Koga H, Takahashi R, et al. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. Oncogene. 1993;8:1913-1919.
3. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science. 1991;253:49-53.
4. Berserga R, Rubin R. Cell cycle and growth control. Crit Rev Eukaryot Gene Exp. 1993;3:47-61.
5. Almasan A, Link SP, Paulson TG, et al. Genetic instability as a consequence of inappropriate entry into and progression through S-phase. Cancer Metastasis Rev. 1995;14:59-73.